11 employees
Weatherwax Bio develops the next generation of induced-proximity medicines.
2019
Weatherwax Biotechnologies raised undisclosed on January 1, 2021
Investors: Healthspan Capital
Weatherwax Biotechnologies raised undisclosed on March 1, 2020
Investors: Bossa Nova Investimentos